CD4 and metabolic syndrome: Whilst similar patterns were also observed for the history of d-drug exposure, nadir CD4 cell count, metabolic syndrome, and the number of years on ART prior to study entry, due to the small number of the sub-study participants and therefore an underpowered analysis, none of these differences were statistically significant in the regression models.